BrianT.PruittMD

Oncology • Amarillo, TX

Breast cancer at Harrington Cancer Center

Join to view full profile

Dr. Pruitt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pruitt's full profile

Already have an account?

Office
1500 Wallace Blvd
Amarillo, TX 79106
Phone+1 806-212-4673

Fax+1 806-352-8890

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1977 - 1980
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1972 - 1975
University of Texas Medical Branch School of MedicineClass of 1972

Certifications & Licensure

TX State Medical License 1981 - 2023
WI State Medical License 1973 - 2019

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
Super Doctor SuperDoctors.com

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

48 citations
Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia.
Seah H. Lim, Yana Zhang, Zhiqing Wang, William V. Esler, David Beggs
Bone Marrow Transplantation. 2005-01-01
2 citations
Double modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: Report of a trial with sequential methotrexate, intravenous (loading dose) folin...
Edward P. Balaban, Mateel Graham, Steve Perkins, Richard G. Sheehan, Eugene P. Frenkel
Cancer Investigation. 1994-01-01
19 citations
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects
Robert S. Witte, Brian T. Pruitt, Douglass C. Tormey, Scot E. Moss, David P. Rose
Cancer. 1986-01-01